No abstract available
Keywords:
complication; dasatinib; pulmonary arterial hypertension; pulmonary hypertension.
MeSH terms
-
Antineoplastic Agents* / therapeutic use
-
Dasatinib / adverse effects
-
Humans
-
Hypertension, Pulmonary* / chemically induced
-
Hypertension, Pulmonary* / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
-
Protein Kinase Inhibitors / adverse effects
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Dasatinib